Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating <scp>miR</scp>‐378a‐3p/<scp>VEGFA</scp>/<scp>RGC</scp>‐32 Axis
Met exerted inhibitory effects on PC through the miR-378a-3p/VEGFA/RGC-32 pathway. Strategies targeting the miR-378a-3p/VEGFA/RGC-32 axis represent a novel avenue for the prevention and treatment of PC.
Authors
- Ying Ding (ORCID: https://orcid.org/0000-0001-5581-3058)
- Yixing Luo (ORCID: https://orcid.org/0000-0001-6223-5217)
- Liang Zhu (ORCID: https://orcid.org/0009-0002-7871-9712)
- Jinli He
Institutions
- Nanchang University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1002/cam4.70446
- Citations
- 4
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.14
Funders
- National Natural Science Foundation of China